J&J Says FTC Probing Efforts To Protect Arthritis Drug Remicade

www.oann.com | 5/29/2019 | Staff
my_new_puppy (Posted by) Level 3
WASHINGTON (Reuters) – The Federal Trade Commission in June issued civil subpoenas to Johnson and Johnson as part of an investigation of whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday....
(Excerpt) Read more at: www.oann.com
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!